Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-16 4:39 pm Purchase | 13G | GALERA THERAPEUTICS INC GRTX | ALPHA PHARMA Investments LLC | 2,750,000 5.056% | 2,750,000 (New Position) | View |
| 2024-04-03 08:08 am Sale | 13G | GALERA THERAPEUTICS INC GRTX | Altamont Pharmaceutical Holdings LLC | 0 0% | -5,280,000 (Position Closed) | View |
| 2024-02-20 6:57 pm Sale | 13D | GALERA THERAPEUTICS INC GRTX | Sofinnova Venture Partners IX L.P. | 0 0% | -3,083,712 (Position Closed) | View |
| 2024-02-14 10:14 am Sale | 13G | GALERA THERAPEUTICS INC GRTX | SECTORAL ASSET MANAGEMENT INC | 0 0% | -1,666,666 (Position Closed) | View |
| 2024-01-16 6:09 pm Purchase | 13G | GALERA THERAPEUTICS INC GRTX | Schneid Yair | 7,110,801 13.073% | 7,110,801 (New Position) | View |
| 2024-01-02 08:35 am Purchase | 13G | GALERA THERAPEUTICS INC GRTX | GSA CAPITAL PARTNERS LLP | 3,892,561 7.156% | 3,892,561 (New Position) | View |
| 2023-12-04 4:32 pm Purchase | 13D | GALERA THERAPEUTICS INC GRTX | Blackstone Holdings I/II GP L.L.C. | 2,289,605 4.2% | 15,000 (+0.66%) | View |
| 2023-11-13 2:24 pm Purchase | 13G | GALERA THERAPEUTICS INC GRTX | Altamont Pharmaceutical Holdings LLC | 5,280,000 12.02% | 5,280,000 (New Position) | View |
| 2023-06-28 4:19 pm Sale | 13G | GALERA THERAPEUTICS INC GRTX | Novo Holdings A/S | 2,100,000 4.9% | -359,021 (-14.60%) | View |
| 2023-02-27 5:43 pm Purchase | 13G | GALERA THERAPEUTICS INC GRTX | Flynn James E | 2,916,401 4.99% | 2,916,401 (New Position) | View |
| 2023-02-13 3:03 pm Purchase | 13G | GALERA THERAPEUTICS INC GRTX | SECTORAL ASSET MANAGEMENT INC | 1,666,666 5.8% | 1,666,666 (New Position) | View |
| 2023-02-09 4:49 pm Purchase | 13D | GALERA THERAPEUTICS INC GRTX | Blackstone Holdings I/II GP L.L.C. | 2,274,605 7.8% | 568,197 (+33.30%) | View |
| 2023-02-03 7:04 pm Sale | 13D | GALERA THERAPEUTICS INC GRTX | Sofinnova Venture Partners IX L.P. | 3,083,712 10.8% | -1,098 (-0.04%) | View |
| 2022-02-14 06:26 am Sale | 13G | GALERA THERAPEUTICS INC GRTX | CITADEL ADVISORS LLC | 163,262 0.6% | -8,471 (-4.93%) | View |
| 2022-02-11 5:14 pm Purchase | 13G | GALERA THERAPEUTICS INC GRTX | Rosalind Advisors Inc. | 1,543,783 5.8% | 1,543,783 (New Position) | View |
| 2022-02-11 4:30 pm Sale | 13G | GALERA THERAPEUTICS INC GRTX | Novartis Bioventures Ltd | 476,085 1.8% | -1,991,875 (-80.71%) | View |
| 2022-02-11 06:11 am Purchase | 13G | GALERA THERAPEUTICS INC GRTX | Blackstone Holdings I/II GP L.L.C. | 1,706,408 6.4% | 19,184 (+1.14%) | View |
| 2022-02-10 08:48 am Sale | 13G | GALERA THERAPEUTICS INC GRTX | ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0% | -1,509,500 (Position Closed) | View |
| 2022-02-02 4:55 pm Sale | 13G | GALERA THERAPEUTICS INC GRTX | Novo Holdings A/S | 2,459,021 9.3% | -500,000 (-16.90%) | View |
| 2021-12-27 4:12 pm Purchase | 13G | GALERA THERAPEUTICS INC GRTX | CITADEL ADVISORS LLC | 171,733 0.6% | 171,733 (New Position) | View |